3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Breast Neoplasms
5
Neoplasm Metastasis
4
Biliary Tract Neoplasms
4
Lung Neoplasms
3
Colorectal Neoplasms
3
Oropharyngeal Neoplasms
2
Neoplastic Cells, Circulating
2
Cholangiocarcinoma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Ewing
1
Recurrence
1
Prostatic Neoplasms
1
Papillomavirus Infections
1
Neurofibrosarcoma
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasm, Residual
1
Hematopoietic and Lymphoid System Neoplasm
1
Gallbladder Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colonic Neoplasms
1
Carcinoma, Lobular
1
Carcinoma, Hepatocellular
1
Interventions
Imatinib Mesylate
12
Sunitinib
10
ripretinib
5
regorafenib
4
Blood Specimen Collection
3
envafolimab
2
Specimen Handling
2
Paclitaxel
2
Magnetic Resonance Spectroscopy
2
IDRX-42
2
Biopsy
2
trastuzumab deruxtecan
1
spartalizumab
1
ribociclib
1
pemigatinib
1
palbociclib
1
olverembatinib
1
nilotinib
1
guadecitabine
1
binimetinib
1
avelumab
1
avapritinib
1
atezolizumab
1
apatinib
1
Temozolomide
1
TAS-116
1
Surgical Instruments
1
Sorafenib
1
Rogaratinib
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastrointestinal Stromal Tumors
×
Liquid Biopsy
×
1 year
×
Clear all
No trials found.